Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1993 Sep 1;90(17):8189-93.
doi: 10.1073/pnas.90.17.8189.

Physicochemical characterization of a ouabain isomer isolated from bovine hypothalamus

Affiliations
Comparative Study

Physicochemical characterization of a ouabain isomer isolated from bovine hypothalamus

A A Tymiak et al. Proc Natl Acad Sci U S A. .

Abstract

Recent reports have shown the presence of a ouabain-like inhibitor of Na+/K(+)-ATPase in humans. We have purified a bovine hypothalamic Na+/K(+)-ATPase inhibitory factor (HIF) by using affinity chromatography combined with HPLC. This inhibitor has a molecular weight of 584 as determined by ion-spray mass spectrometry, making it isobaric with ouabain. Glycosidase treatment or acid hydrolysis of HIF released only L-rhamnose, the hexose isomer found in ouabain, as detected by chiral GC/MS. Additionally, enzymatically generated desrhamnosyl HIF was found to have a molecular weight of 438, as does ouabagenin, the aglycone of ouabain. HIF and its aglycone were indistinguishable from ouabain and ouabagenin, respectively, by reversed-phase HPLC retention times. However, derivatization with naphthoylimidazole followed by HPLC revealed different retention times for naphthoylation products of HIF and ouabain. Subsequent CD spectroscopy on isolated naphthoylation products of HIF and ouabain confirmed that they were different. This study provides chromatographic and spectroscopic evidence that ouabain and HIF are isomeric cardenolides. The structural difference is presumed to account for the significant differences in biological properties observed for HIF and ouabain.

PubMed Disclaimer

References

    1. Clin Chem. 1970 Aug;16(8):722-5 - PubMed
    1. Nature. 1961 Dec 2;192:871-2 - PubMed
    1. Am J Physiol. 1977 May;232(5):C165-73 - PubMed
    1. Chem Pharm Bull (Tokyo). 1977 Apr;25(4):714-30 - PubMed
    1. Proc Natl Acad Sci U S A. 1979 Sep;76(9):4658-60 - PubMed

Publication types

LinkOut - more resources